Yongping CrawfordAssociate Director at NGM Biopharmaceuticals
Yongping Crawford is Director, Biologics, at NGM Biopharmaceuticals. She heads the Cell Line Development (CLD) and Engineering group at NGM and is responsible for all internal and outsourcing CLD activities. She also serves as a team lead for several programs including ophthalmology and immune-oncology projects. She and her team have built a proprietary expression platform that offers high yields using a simple 14-day fed-batch and a fast-track timeline. Previously, Yongping was a group leader at Genentech, where she led the effort in developing and implementing a Targeted Integration host for CLD. Yongping received her PhD from University of California, San Francisco, and completed her postdoctoral training at Genentech.